BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18335652)

  • 1. Treatment of hyperkeratosis with Kerafoam emollient foam (30% urea) to assess effectiveness and safety within a clinical setting: a case study report.
    Goldstein JA; Gurge RM
    J Drugs Dermatol; 2008 Feb; 7(2):159-62. PubMed ID: 18335652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam.
    Trumbore MW; Goldstein JA; Gurge RM
    J Drugs Dermatol; 2009 Mar; 8(3):299-304. PubMed ID: 19271381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).
    Eberlein B; Eicke C; Reinhardt HW; Ring J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):73-82. PubMed ID: 18181976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of topical hydrating and emollient lotion containing 10% urea ISDIN® plus dexpanthenol (Ureadin Rx 10) in the treatment of skin xerosis and pruritus in hemodialyzed patients: an open prospective pilot trial.
    Castello M; Milani M
    G Ital Dermatol Venereol; 2011 Oct; 146(5):321-5. PubMed ID: 21956268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salicylic Acid 6% in an ammonium lactate emollient foam vehicle in the treatment of mild-to-moderate scalp psoriasis.
    Kircik L
    J Drugs Dermatol; 2011 Mar; 10(3):270-3. PubMed ID: 21369643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial.
    Shaibani A; Biton V; Rauck R; Koch B; Simpson J
    Eur J Pain; 2009 May; 13(5):458-63. PubMed ID: 18619874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple nonmelanoma skin cancers in a patient with epidermolytic hyperkeratosis on long-standing retinoid therapy.
    Sarnoff DS; Saini R
    J Drugs Dermatol; 2008 May; 7(5):475-8. PubMed ID: 18505142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pretreatment with a urea-containing emollient on nickel allergic skin reactions.
    Kuzmina N; Nyrén M; Lodén M; Edlund F; Emtestam L
    Acta Derm Venereol; 2005; 85(1):9-12. PubMed ID: 15848983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis.
    Mraz S; Leonardi C; Colón LE; Johnson LA
    J Dermatolog Treat; 2008; 19(6):354-9. PubMed ID: 18923991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of bullous congenital ichthyosiform erythroderma with erythromycin.
    ten Freyhaus K; Kaiser HW; Proelss J; Tüting T; Bieber T; Wenzel J
    Dermatology; 2007; 215(1):81-3. PubMed ID: 17587848
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Belgian observational drug utilization study of pimecrolimus cream 1% in routine daily practice in atopic dermatitis.
    De Backer M; Morren MA; Boonen H; Boyden B; Vertruyen A; Lecomte P; Paquay C; Lesaffre E; Lambert J
    Dermatology; 2008; 217(2):156-63. PubMed ID: 18525202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of an emollient body wash for patients with chronic winter dry skin.
    Hoffman L; Subramanyan K; Johnson AW; Tharp MD
    Dermatol Ther; 2008; 21(5):416-21. PubMed ID: 18844721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidcermolytic hyperkeratosis: a case report.
    Achar A; Naskar B; Laha R; Ray S
    J Indian Med Assoc; 2009 Mar; 107(3):171-2. PubMed ID: 19810387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of cutaneous xerosis with emollient treatment in sub-Saharan African patients.
    Boralevi F; Meledie N'Djong AP; Yao Yoboue P; Faye O; Dieng MT; Coniquet S; Atadokpede F; Niamba PA; Delarue A; Cazeau C
    Int J Dermatol; 2017 Apr; 56(4):467-473. PubMed ID: 28205205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effective, cosmetically acceptable, novel hydro-gel emollient for the management of dry skin conditions.
    Wynne A; Whitefield M; Dixon AJ; Anderson S
    J Dermatolog Treat; 2002 Jun; 13(2):61-6. PubMed ID: 12060503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, single-blind comparison of the efficacy, tolerability and cosmetic acceptance of Propyless or Fenuril treatment of patients with dry skin.
    Faergemann J; Olsson P; Svensson A
    Acta Derm Venereol; 2009; 89(3):305-7. PubMed ID: 19479133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.